{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:40:06Z","timestamp":1789080006025,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI144182\\u201301"],"award-info":[{"award-number":["1U19AI144182\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI125421-01A1"],"award-info":[{"award-number":["R01-AI125421-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126709","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:07:27Z","timestamp":1736917647000},"page":"126709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria"],"prefix":"10.1016","volume":"48","author":[{"given":"Epshita A.","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie E.","family":"Fegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Zeppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa G.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor F.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Gray-Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.126709_bb0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00003081-197503000-00006","article-title":"Acute pelvic inflammatory disease: current concepts of pathogenesis, etiology, and management","volume":"18","author":"Eschenbach","year":"1975","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126709_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-102-2-229","article-title":"Gonococcal infections","volume":"102","author":"Hook","year":"1985","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126709_bb0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"issue":"50","key":"10.1016\/j.vaccine.2025.126709_bb0025","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.vaccine.2025.126709_bb0030","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/1040841X.2017.1329276","article-title":"The next chapter for group B meningococcal vaccines","volume":"44","author":"Wang","year":"2018","journal-title":"Crit Rev Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2025.126709_bb0040","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection--serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126709_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/14760584.2017.1258308","article-title":"The global meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection","volume":"16","author":"Borrow","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126709_bb0050","doi-asserted-by":"crossref","first-page":"1649.e1","DOI":"10.1016\/j.cmi.2022.07.004","article-title":"Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme","volume":"28","author":"Carr","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1623","key":"10.1016\/j.vaccine.2025.126709_bb0055","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0147","article-title":"The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?","volume":"368","author":"Maiden","year":"2013","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126709_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037358","article-title":"\u2018Be on the TEAM\u2019 study (teenagers against meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents","volume":"10","author":"Carr","year":"2020","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126709_bb0065","doi-asserted-by":"crossref","first-page":"1649.e1","DOI":"10.1016\/j.cmi.2022.07.004","article-title":"Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme","volume":"28","author":"Carr","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126709_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10070906","article-title":"Exploring the ability of meningococcal vaccines to elicit mucosal immunity: insights from humans and mice","volume":"10","author":"Currie","year":"2021","journal-title":"Pathogens"},{"issue":"9960","key":"10.1016\/j.vaccine.2025.126709_bb0075","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial","volume":"384","author":"Read","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.126709_bb0080","article-title":"The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent population","volume":"43","author":"Leong","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14760584.2022.2003708","article-title":"4CMenB vaccine and its role in preventing transmission and inducing herd immunity","volume":"21","author":"McMillan","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126709_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01668-19","article-title":"Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"mBio"},{"issue":"20","key":"10.1016\/j.vaccine.2025.126709_bb0095","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1073\/pnas.93.20.11109","article-title":"Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: two closely related bacteria expressing two different pathogenicities","volume":"93","author":"Tinsley","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10102","key":"10.1016\/j.vaccine.2025.126709_bb0100","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126709_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008602","article-title":"The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae","volume":"16","author":"Leduc","year":"2020","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126709_bb0110","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S1473-3099(24)00031-8","article-title":"Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK","volume":"24","author":"Ladhani","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126709_bb0115","article-title":"The Neisseria gonorrhoeae vaccine candidate NHBA elicits antibodies that are bactericidal, Opsonophagocytic and that reduce gonococcal adherence to epithelial cells","volume":"8","author":"Semchenko","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"51","key":"10.1016\/j.vaccine.2025.126709_bb0120","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2020.10.077","article-title":"A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection","volume":"38","author":"Sikora","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126709_bb0125","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","article-title":"Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins a and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice","volume":"73","author":"Price","year":"2005","journal-title":"Infect Immun"},{"issue":"41","key":"10.1016\/j.vaccine.2025.126709_bb0130","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1016\/j.vaccine.2007.07.038","article-title":"Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice","volume":"25","author":"Price","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126709_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fimmu.2019.00247","article-title":"Utility of hybrid transferrin binding protein antigens for protection against pathogenic Neisseria species","volume":"10","author":"Fegan","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126709_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.tim.2022.01.017","article-title":"Targeting bacterial transferrin and lactoferrin receptors for vaccines","volume":"30","author":"Schryvers","year":"2022","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126709_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00949-20","article-title":"Molecular insight into TdfH-mediated zinc piracy from human calprotectin by Neisseria gonorrhoeae","volume":"11","author":"Kammerman","year":"2020","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126709_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007937","article-title":"The novel interaction between Neisseria gonorrhoeae TdfJ and human S100A7 allows gonococci to subvert host zinc restriction","volume":"15","author":"Maurakis","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.126709_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmicb.2011.00107","article-title":"Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections","volume":"2","author":"Jerse","year":"2011","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126709_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003509","article-title":"In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa","volume":"9","author":"Johswich","year":"2013","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126709_bb0165","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jix162","article-title":"Discordant effects of licensed meningococcal serogroup B vaccination on invasive disease and nasal colonization in a humanized mouse model","volume":"215","author":"Buckwalter","year":"2017","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126709_bb0170","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.vaccine.2015.01.057","article-title":"A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice","volume":"33","author":"Pajon","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126709_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003559","article-title":"Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection","volume":"9","author":"Gulati","year":"2013","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00421-17","article-title":"Intravaginal Administration of Interleukin 12 during genital gonococcal infection in mice induces immunity to heterologous strains of","volume":"3","author":"Liu","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2025.126709_bb0185","article-title":"Protection against Neisseria meningitidis nasopharyngeal colonization relies on antibody opsonization and phagocytosis by neutrophils","author":"Currie","year":"2024","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126709_bb0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants--a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126709_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2567.2009.03164.x","article-title":"T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection","volume":"129","author":"Korsholm","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"issue":"5831","key":"10.1016\/j.vaccine.2025.126709_bb0210","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid a as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.vaccine.2025.126709_bb0215","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126709_bb0220","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126709_bb0225","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126709_bb0230","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0264-410X(95)00240-2","article-title":"MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice","volume":"14","author":"Higgins","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126709_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci Rep"},{"issue":"21\u221222","key":"10.1016\/j.vaccine.2025.126709_bb0240","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0264-410X(02)00193-7","article-title":"DDA adjuvant induces a mixed Th1\/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine","volume":"20","author":"Klinguer-Hamour","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126709_bb0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1600-0625.2002.110204.x","article-title":"Induction of skewed Th1\/Th2 T-cell differentiation via subcutaneous immunization with Freund\u2019s adjuvant","volume":"11","author":"Shibaki","year":"2002","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126709_bb0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0161-5890(83)90062-7","article-title":"Mouse IgG antibodies have subclass associated affinity differences","volume":"20","author":"Sarvas","year":"1983","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0022-1759(94)00331-P","article-title":"Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay","volume":"181","author":"Gupta","year":"1995","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126709_bb0260","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.4049\/jimmunol.180.9.6159","article-title":"A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection","volume":"180","author":"Yang","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126709_bb0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.micinf.2017.10.001","article-title":"Comparative analysis of clinics, pathologies and immune responses in BALB\/c and C57BL\/6 mice infected with Streptobacillus moniliformis","volume":"20","author":"Fornefett","year":"2018","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0270","doi-asserted-by":"crossref","first-page":"14917","DOI":"10.1038\/s41598-021-94364-5","article-title":"Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice","volume":"11","author":"Rice","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126709_bb0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/OLQ.0000000000001332","article-title":"Planning for a gonococcal vaccine: a narrative review of vaccine development and public health implications","volume":"48","author":"Abara","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/QCO.0000000000000997","article-title":"STI pathogens in the oropharynx: update on screening and treatment","volume":"37","author":"Chow","year":"2024","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0285","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/QCO.0000000000000697","article-title":"Emergence of a novel urogenital-tropic Neisseria meningitidis","volume":"34","author":"Bazan","year":"2021","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126709_bb0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","article-title":"The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers","volume":"27","author":"Cornelissen","year":"1998","journal-title":"Mol Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126709_bb0295","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0264-410X(93)90045-Y","article-title":"Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals","volume":"11","author":"Danve","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126709_bb0300","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/iai.63.3.884-890.1995","article-title":"Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines","volume":"63","author":"Lissolo","year":"1995","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/iai.65.1.55-63.1997","article-title":"Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains","volume":"65","author":"Rokbi","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126709_bb0310","article-title":"Bivalent TbpB formulations elicit broad spectrum coverage against Neisseria gonorrhoeae","author":"Fegan","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.vaccine.2025.126709_bb0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2016.08.034","article-title":"The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: the immunological consequences of the biodistribution profile","volume":"239","author":"Schmidt","year":"2016","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126709_bb0320","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201141855","article-title":"A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo","volume":"42","author":"Pantel","year":"2012","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126709_bb0330","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.181.2.713","article-title":"T cell genetic background determines default T helper phenotype development in vitro","volume":"181","author":"Hsieh","year":"1995","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126709_bb0335","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2353\/ajpath.2008.070776","article-title":"Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis","volume":"172","author":"Schulte","year":"2008","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/IAI.00711-09","article-title":"Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses","volume":"78","author":"Packiam","year":"2010","journal-title":"Infect Immun"},{"issue":"45","key":"10.1016\/j.vaccine.2025.126709_bb0345","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1016\/j.vaccine.2008.08.020","article-title":"Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice","volume":"26","author":"Song","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126709_bb0350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2025.126709_bb0355","article-title":"Meningococcal vaccine Bexsero elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection","author":"Zeppa","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.vaccine.2025.126709_bb0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-62703-691-7_2","article-title":"Stable expression clones and auto-induction for protein production in E. coli","volume":"1091","author":"Studier","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2025.126709_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113037","article-title":"Development of a non-biased, high-throughput ELISA for the rapid evaluation of immunogenicity and cross-reactivity","volume":"493","author":"Fegan","year":"2021","journal-title":"J Immunol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:01:34Z","timestamp":1743861694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":73,"alternative-id":["S0264410X25000064"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126709","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.07.611809","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126709"}}